JP Morgan Chase
NUVB icon

JP Morgan Chase’s Nuvation Bio NUVB Stock Holding History

JP Morgan Chase’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,500
Closed -$91.1K – 7970
2026
Q1 		$91.1K Buy
+22,500
New +$125K ﹤0.01% 5880

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

JP Morgan Chase's NUVB Position: Q2 2026 in Review

JP Morgan Chase reduced its Nuvation Bio (NUVB) stake by 4.4% in Q2 2026, selling an estimated $115K and leaving 515,696 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #3907.

JP Morgan Chase first reported a position in NUVB in Q2 2021 and has held it in 21 quarters since. The position peaked at $5.71M in Q4 2021. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • JP Morgan Chase held 515,696 shares of Nuvation Bio worth $2.89M as of Q2 2026.
  • JP Morgan Chase sold 23,466 Nuvation Bio shares in Q2 2026, an estimated $115K.
  • Nuvation Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3907 holding.
  • JP Morgan Chase first reported a position in Nuvation Bio in Q2 2021 and has held it in 21 quarters since.
  • JP Morgan Chase's Nuvation Bio position peaked at $5.71M in Q4 2021.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.